The competitive landscape is intensifying with other big pharma companies like Boehringer Ingelheim, Amgen, and Roche also investing heavily, offering novel mechanisms, formulations, and dosing regimens
By attenuating NNMT activity, 5Amino1MQ has been observed in preclinical settings to elevate NAD+ availability, enhance metabolic flux, and upregulate downstream signaling programs associated with cellular stress responses and energy expenditure (e.g., SIRT1)
Lixisenatide reduced urinary albumin-to-creatinine ratio (UACR) versus placebo at 108 weeks of follow-up by 10% (p = 0.004)
However, its long-term safety, economic accessibility, and optimization of individualized treatment plans remain key issues that need to be addressed in the future
Dogs on nutritionally inadequate diets, or those fed predominantly grain-based or plant-based diets without appropriate supplementation, may develop secondary deficiency over time